快速检索:        
    
在线办公系统
在线期刊
下载专区
排行榜
友情链接
扫描微信二维码,获取更多信息
张玉五,薛颖,张秉乾.丹参对恶性淋巴瘤患者高血浆纤维蛋白原的影响[J].中国中西医结合杂志,1988,(10):607-608,582
丹参对恶性淋巴瘤患者高血浆纤维蛋白原的影响
Effect of Salvia miltiorrhiza on Hyperfibrinogen in Patients with Malignant Lymphoma
免费下载全文  查看/发表评论  下载PDF阅读器
  
DOI:
中文关键词:  血浆纤维蛋白原  恶性淋巴瘤  丹参  增效作用  恶性肿瘤患者  治疗方案  纤溶作用  统计学处理  负相关  肿瘤细胞
英文关键词:
基金项目:
作者单位
张玉五 西安医科大学第一附属医院 
薛颖 西安医科大学第一附属医院 
张秉乾 西安医科大学第一附属医院 
摘要点击次数: 1093
全文下载次数: 892
中文摘要:
      对35例恶性淋巴瘤患者分组治疗,结果表明丹参对 COP 治疗方案有增效作用。血浆纤维蛋白原(Fg)测定显示恶性淋巴瘤患者组较正常对照组高(P<0.01)。COP方案治疗组疗后血浆 Fg 较疗前有所降低(P>0.5);丹参—COP 方案治疗组血浆 Fg 疗后较疗前明显降低(P<0.01)。血浆 Fg 含量与疗效呈负相关。提示丹参的促纤溶作用是其抗肿瘤作用的重要机制之一。
英文摘要:
      35 cases of malignant lymphoma were divided into two groups randomly,22 cases of which were treated with Salvia miltiorrhiza(SM)-COP therapy,and only 13 cases by COP therapy.In terms o’f short-term effect,it has been found that SM-COP therapy was more effective than COP therapy,P< 0.01.The experimental study showed that one of the mechanisms of SM against tumor is improving the hypercoagulation state through lowering the serum hyperfibrinogen,from 3.626±1.638 to 2.343± 0.576 mg/dl,P<0.01,which is significant in showing that promoting the fibrinolytic activity was closely related with the therapeutic effect,and was one of the antitumor mechanisms.
关闭